open access

Vol 7, No 1 (2002)
Original papers
Published online: 2002-01-01
Submitted: 2001-07-06
Get Citation

Assessment of early toxicity of concomitant radio-chemotherapy in the treatment of locally advanced cervical cancer

Andrzej Wieczorek, Piotr Kędzierawski, Jolanta Smok-Kalwat, Paweł Banatkiewicz
DOI: 10.1016/S1507-1367(02)70975-9
·
Rep Pract Oncol Radiother 2002;7(1):11-14.

open access

Vol 7, No 1 (2002)
Original papers
Published online: 2002-01-01
Submitted: 2001-07-06

Abstract

Introduction

The aim of this paper was to assess early toxicity and feasibility of concomitant radiochemotherapy in the treatment of locally advanced cervical cancer in daily routine clinical practise.

Material and methods

Between 1st of May 2000 and 15th of November 2000, twenty one patients suffering from stage IIB and IIIB (FIGO classification) cervical carcinoma were treated in the Radiotherapy Department of the Holycross Cancer Centre by concomitant radio-chemotherapy. Early toxicity of the skin, the lower gastrointestinal system and the genitourinary system was assessed according to acute radiation morbidity scoring criteria EORTC/RTOG. Leukopenia, thrombocytopenia, anemia, nausea, vomiting and nephrotoxicity were scored according to the WHO scale.

Results

There were no treatment-related deaths and no treatment breaks in radiotherapy due to acute toxicity. Only 48% of patients completed all 6 courses of cis-platin. The main causes of withdrawals from consecutive cycles of chemotherapy were: leucopenia - grade 2 or 3, thrombocytopenia - grade 3 and patient refusal. One patient developed acute renal failure. Other adverse effects did not exceed grade 2.

Conclusions

Concomitant radio-chemotherapy in the treatment of locally advanced cervical cancer was feasible and featured acceptable toxicity. Haematologic adverse effects were the main reasons of discontinued chemotherapy. Radiotherapy was well tolerated and all patients completed the whole course.

Abstract

Introduction

The aim of this paper was to assess early toxicity and feasibility of concomitant radiochemotherapy in the treatment of locally advanced cervical cancer in daily routine clinical practise.

Material and methods

Between 1st of May 2000 and 15th of November 2000, twenty one patients suffering from stage IIB and IIIB (FIGO classification) cervical carcinoma were treated in the Radiotherapy Department of the Holycross Cancer Centre by concomitant radio-chemotherapy. Early toxicity of the skin, the lower gastrointestinal system and the genitourinary system was assessed according to acute radiation morbidity scoring criteria EORTC/RTOG. Leukopenia, thrombocytopenia, anemia, nausea, vomiting and nephrotoxicity were scored according to the WHO scale.

Results

There were no treatment-related deaths and no treatment breaks in radiotherapy due to acute toxicity. Only 48% of patients completed all 6 courses of cis-platin. The main causes of withdrawals from consecutive cycles of chemotherapy were: leucopenia - grade 2 or 3, thrombocytopenia - grade 3 and patient refusal. One patient developed acute renal failure. Other adverse effects did not exceed grade 2.

Conclusions

Concomitant radio-chemotherapy in the treatment of locally advanced cervical cancer was feasible and featured acceptable toxicity. Haematologic adverse effects were the main reasons of discontinued chemotherapy. Radiotherapy was well tolerated and all patients completed the whole course.

Get Citation

Keywords

early toxicity; concomitant radio-chemotherapy; locally advanced cervical cancer

About this article
Title

Assessment of early toxicity of concomitant radio-chemotherapy in the treatment of locally advanced cervical cancer

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 7, No 1 (2002)

Pages

11-14

Published online

2002-01-01

DOI

10.1016/S1507-1367(02)70975-9

Bibliographic record

Rep Pract Oncol Radiother 2002;7(1):11-14.

Keywords

early toxicity
concomitant radio-chemotherapy
locally advanced cervical cancer

Authors

Andrzej Wieczorek
Piotr Kędzierawski
Jolanta Smok-Kalwat
Paweł Banatkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl